Clinical trial
Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic…
NCT00004077 · Medical Research Council, Other · Completed
Key facts
| NCT number | NCT00004077 |
|---|---|
| Title | Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer |
| Official title | A Study of Paclitaxel, Cisplatin and Ifosfamide as Induction Therapy in the Treatment of Patients Relapsing After BEP Chemotherapy for Metastatic Germ Cell Tumors |
| Lead sponsor | Medical Research Council, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Testicular Germ Cell Tumor |
| Intervention type | Drug |
| Interventions | cisplatin, ifosfamide, paclitaxel |
| Enrollment | 25 |
| Start date | May 1, 1996 |
| Completion | Jul 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 19, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: